ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,400 | -21.3% | 10,000 | -9.6% | 0.00% | 0.0% |
| Q2 2023 | $264,839 | -3.0% | 11,058 | -23.8% | 0.00% | 0.0% |
| Q1 2023 | $272,946 | +13.7% | 14,503 | -3.9% | 0.00% | 0.0% |
| Q4 2022 | $240,153 | -34.2% | 15,085 | -3.5% | 0.00% | 0.0% |
| Q4 2021 | $365,000 | +31.3% | 15,628 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $278,000 | -32.2% | 16,743 | -0.4% | 0.00% | 0.0% |
| Q2 2021 | $410,000 | -13.9% | 16,804 | -8.9% | 0.00% | -50.0% |
| Q1 2021 | $476,000 | -9.0% | 18,445 | +88.4% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +32.7% | 9,790 | +2.4% | 0.00% | 0.0% |
| Q3 2020 | $394,000 | -3.7% | 9,562 | +13.3% | 0.00% | 0.0% |
| Q2 2020 | $409,000 | +15.2% | 8,436 | +0.5% | 0.00% | 0.0% |
| Q1 2020 | $355,000 | +34.0% | 8,397 | +9.0% | 0.00% | 0.0% |
| Q1 2017 | $265,000 | -15.9% | 7,703 | -22.2% | 0.00% | -33.3% |
| Q3 2016 | $315,000 | +29.1% | 9,901 | +31.5% | 0.00% | +50.0% |
| Q2 2016 | $244,000 | +3.8% | 7,531 | -10.0% | 0.00% | 0.0% |
| Q1 2016 | $235,000 | – | 8,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |